The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.50
Bid: 17.00
Ask: 18.00
Change: -0.25 (-1.41%)
Spread: 1.00 (5.882%)
Open: 17.75
High: 17.75
Low: 17.50
Prev. Close: 17.75
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix's LeanBiome to be launched under MuscleTech

Mon, 15th Jan 2024 10:40

(Alliance News) - OptiBiotix Health PLC on Monday announced the launch of LeanBiome in sports nutrition brand, MuscleTech.

The York, England-based life sciences company said LeanBiome will be incorporated in Muscletech Nitro Tech's Ripped range, which is a protein powder "designed to support athletes who want to lose fat and build lean muscle."

LeanBiome will be launched in Europe and the UK across multiple e-commerce sites and distribution channels, OptiBiotix said.

The product is currently being advertised on social media by MuscleTech ahead of online and instore launches with multiple retailers in Sweden, France, Poland, Germany, the Netherlands, Greece and the UK.

OptiBiotix's LeanBiome is a "scientifically formulated sports nutrition ingredient which has been developed to "support athletes seeking to increase lean muscle mass and to change their body composition."

OptiBiotix Chief Executive Officer Stephen OHara said: "We are very pleased to announce the launch of LeanBiome with such a well-known and internationally respected sports brand such as Muscletech. LeanBiome has been formulated to support anyone interested in improving their fitness for leisure or the elite athlete. It is supported by multiple published clinical studies which show it helps reduce body fat around the waist and hips, improving body leanness whilst enhancing the diversity of the gut microbiome to improve stamina and overall fitness.

"LeanBiomeĀ® is a unique product which is increasingly being recognised by major sports brands as a key differentiator from existing products and has the potential to have a major impact in the sports nutrition and health and fitness markets."

Shares in OptiBiotix were up 2.0% at 25.00 pence each in London on Monday morning.

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
10 Aug 2021 11:24

OptiBiotix extends deal with Seed Health to other territories

(Sharecast News) - Life sciences company OptiBiotix Health announced on Tuesday that its wholly-owned subsidiary ProBiotix Health has extended the territories of its original agreement with Seed Health, for the production, promotion, marketing and commercialisation of products containing 'LPLDL'.

Read more
5 Aug 2021 18:07

IN BRIEF: OptiBiotix Health confident in annual outlook on sales rise

IN BRIEF: OptiBiotix Health confident in annual outlook on sales rise

Read more
5 Aug 2021 13:43

OptiBiotix revenues see healthy rise in first half

(Sharecast News) - Obesity, cardiovascular and diabetes-focussed life sciences company OptiBiotix Health reported first-half total invoiced sales of 'LPLDL' and 'SlimBiome' as ingredient or final product of £1.074m in an update on Thursday, representing a year-on-year increase of 44.3% and ahead of its expectations for the period.

Read more
5 Aug 2021 10:44

AIM WINNERS & LOSERS: Mkango rises on deal to wholly own Songwe Hill

AIM WINNERS & LOSERS: Mkango rises on deal to wholly own Songwe Hill

Read more
6 Jul 2021 11:30

IN BRIEF: OptiBiotix continues Asian expansion with Inscobee deal

IN BRIEF: OptiBiotix continues Asian expansion with Inscobee deal

Read more
2 Jul 2021 15:52

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
17 Jun 2021 13:21

TRADING UPDATES: Anpario performance improves; Sumo outlook confident

TRADING UPDATES: Anpario performance improves; Sumo outlook confident

Read more
17 Jun 2021 12:13

OptiBiotix operating losses narrow as revenue surges

(Sharecast News) - Life sciences company OptiBiotix Health reported a 104% improvement in its full-year revenue on Thursday, to £1.52m.

Read more
21 Apr 2021 14:44

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

Read more
16 Apr 2021 15:17

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

Read more
23 Mar 2021 15:04

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

Read more
23 Mar 2021 08:06

Optibiotix names René Kamminga as CEO of subsidiary

(Sharecast News) - Biotechnology company Optibiotix Health named René Kamminga as chief executive officer of its OptiBiotix Ltd subsidiary on Tuesday, subject to completion of normal regulatory due diligence.

Read more
17 Mar 2021 15:50

OptiBiotix expands product ranges, sees positive drug trial results

OptiBiotix expands product ranges, sees positive drug trial results

Read more
18 Feb 2021 11:13

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

Read more
2 Feb 2021 14:38

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.